Cargando…
Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
BACKGROUND: The early-stage lung adenocarcinoma (LUAD) rate has increased with heightened public awareness and lung cancer screening implementation. Lipid metabolism abnormalities are associated with lung cancer initiation and progression. However, the comprehensive features and clinical significanc...
Autores principales: | Zhu, Mingchuang, Zeng, Qingpeng, Fan, Tao, Lei, Yuanyuan, Wang, Feng, Zheng, Sufei, Wang, Xinfeng, Zeng, Hui, Tan, Fengwei, Sun, Nan, Xue, Qi, He, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867215/ https://www.ncbi.nlm.nih.gov/pubmed/35222371 http://dx.doi.org/10.3389/fimmu.2022.783495 |
Ejemplares similares
-
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
por: Zhu, Mingchuang, et al.
Publicado: (2022) -
Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2020) -
Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature
por: Shen, Lesang, et al.
Publicado: (2023) -
Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma
por: Yi, Lilan, et al.
Publicado: (2022) -
A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
por: Liu, Chengming, et al.
Publicado: (2021)